Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,306 | -23,234 | -123,462 | -96,537 | -63,212 |
| Depreciation Amortization | 469 | 240 | 1,221 | 853 | 583 |
| Other Working Capital | -10,980 | -10,134 | 4,680 | 10,785 | 8,592 |
| Other Operating Activity | 4,796 | 2,300 | 13,546 | 10,806 | 7,289 |
| Operating Cash Flow | $-50,021 | $-30,828 | $-104,015 | $-74,093 | $-46,748 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -98 | -90 | -65 |
| Investing Cash Flow | $N/A | $N/A | $-98 | $-90 | $-65 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 244 | N/A | 336 | 187 | 173 |
| Other Financing Activity | -32 | -13 | -259 | -229 | -174 |
| Financing Cash Flow | $212 | $-13 | $77 | $-42 | $-1 |
| Beginning Cash Position | 111,471 | 111,471 | 215,507 | 215,507 | 215,507 |
| End Cash Position | 61,662 | 80,630 | 111,471 | 141,282 | 168,693 |
| Net Cash Flow | $-49,809 | $-30,841 | $-104,036 | $-74,225 | $-46,814 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,021 | -30,828 | -104,015 | -74,093 | -46,748 |
| Capital Expenditure | N/A | N/A | -98 | -90 | -65 |
| Free Cash Flow | -50,021 | -30,828 | -104,113 | -74,183 | -46,813 |